Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Octenidine dihydrochloride + phenoxyethanol is a topical antiseptic and disinfectant used for repeated, time-limited antiseptic treatment of skin, mucous membranes, minor wounds, and the oral region. The combination exhibits a broad spectrum of antimicrobial activity, with bactericidal, fungicidal, and antiviral effects. Octenidine dihydrochloride acts as a cation-active compound that interacts with microbial cell wall and membrane components, leading to cell function destruction. Phenoxyethanol increases cell membrane permeability, specifically for potassium ions, thereby exerting antimicrobial action. The combination is effective against Gram-positive and Gram-negative bacteria, yeasts, skin fungi, and some viruses (e.g., hepatitis B)[1][5][8]. It is used in wound care, preoperative skin preparation, pediatric care, oral mucosa disinfection, and acne management[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on octenidine dihydrochloride + phenoxyethanol.